Brief: Orchard Therapeutics Reports Qtrly Loss Per Share $0.46
27/02/2020 13:10
Feb 27 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS REPORTS 2019 FINANCIAL RESULTS AND
REVIEWS
KEY STRATEGIC PRIORITIES FOR 2020
* ORCHARD THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.46
* ORCHARD THERAPEUTICS PLC - CASH, CASH EQUIVALENTS AND
INVESTMENTS $325 MILLION AS OF DEC.31, 2019
Source text for Eikon: ID:nGNX1DL8dn
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln